Influence of increased membrane cholesterol on membrane fluidity and cell function in human red blood cells

Wiley - Tập 8 Số 4 - Trang 413-430 - 1978
Richard A. Cooper1
1Hematology-Oncology Section, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104

Tóm tắt

AbstractCholesterol and phospholipid are the two major lipids of the red cell membrane. Cholesterol is insoluble in water but is solubilized by phospholipids both in membranes and in plasma lipoproteins. Morever, cholesterol exchanges between membranes and lipoproteins. An equilibrium partition is established based on the amount of cholesterol relative to phospholipid (C/PL) in these two compartments.Increases in the C/PL of red cell membranes have been studied under three conditions: First, spontaneous increases in vivo have been observed in the spur red cells of patients with severe liver disease; second, similar red cell changes in vivo have been induced by the administration of cholesterol‐enriched diets to rodents and dogs; third, increases in membrane cholesterol have been induced in vitro by enriching the C/PL of the lipoprotein environment with cholesterol‐phospholipid dispersions (liposomes) having a C/PL of >1.0. In each case, there is a close relationship between the C/PL of the plasma environment and the C/PL of the red cell membrane. In vivo, the C/PL mole ratio of red cell membranes ranges from a normal value of 0.9–1.0 to values which approach but do not reach 2.0. In vitro, this ratio approaches 3.0.Cholesterol enrichment of red cell membranes directly influences membrane lipid fluidity, as assessed by the rotational diffusion of hydrophobic fluorescent probes such as diphenyl hexatriene (DPH). A close correlation exists between increases in red cell membrane C/PL and decreases in membrane fluidity over the range of membrane C/PL from 1.0 to 2.0; however, little further change in fluidity occurs when membrane C/PL is increased to 2.0–3.0.Cholesterol enrichment of red cell membranes is associated with the transformation of cell contour to one which is redundant and folded, and this is associated with a decrease in red cell filterability in vitro. Circulation in vivo in the presence of the slpeen further modifies cell shape to a spiny, irregular (spur) form, and the survival of cholesterol‐rich red cells is decreased in the presence of the spleen. Although active Na‐K transport is not influenced by cholesterol enrichment of human red cells, several carrier‐mediated transport pathways are inhibited. We have demonstrated this effect for the cotransport of Na + K and similar results have been obtained by others in studies of organic acid transport and the transport of small neutral molecules such as erythritol and glycerol.Thus, red cell membrane C/PL is sensitive to the C/PL of the plasma environment. Increasing membrane C/PL causes a decrease in membrane fluidity, and these changes are associated with a reduction in membrane permeability, a distortion of cell contour and filterability and a shortening of the survival of redcells in vivo.

Từ khóa


Tài liệu tham khảo

Rouser G, 1968, Biological Membranes, 6

10.1007/BF02532509

10.1016/0005-2736(72)90030-2

10.1007/BF02533637

10.1021/bi00595a021

10.1172/JCI107478

10.1172/JCI106315

10.1016/0304-4157(76)90008-3

10.1038/newbio237042a0

Chapman D, 1968, Biological Membranes: Physical fact and function, 125

10.1007/BF01869676

10.1016/0005-2736(76)90183-8

10.1021/bi00705a006

10.1172/JCI108747

10.1016/0005-2736(75)90121-2

Shattil SJ, 1977, Clin Res, 25, 347A

10.1073/pnas.71.2.522

10.1128/BR.39.3.232-256.1975

10.1016/0005-2787(76)90499-8

10.1083/jcb.72.3.744

10.1016/S0022-2275(20)40207-X

10.1007/BF02533001

10.1016/0010-406X(69)92089-1

10.1016/0306-4565(76)90030-9

10.1016/0005-2736(75)90258-8

Goldman SS, 1975, Am J Phys, 228, 834, 10.1152/ajplegacy.1975.228.3.834

10.3181/00379727-78-19064

10.1172/JCI102853

Gould RG, 1955, J Lab Clin Med, 46, 372

Murphy JR, 1962, J Lab Clin Med, 60, 571

Ashworth LAE, 1964, Biochim Biophys Acta, 84, 182

Basford JM, 1964, Biochim Biophys Acta, 84, 764

10.1172/JCI107145

10.1172/JCI107901

10.1073/pnas.73.10.3680

10.1172/JCI106148

10.1016/0005-2760(67)90019-7

10.1016/0005-2760(71)90178-0

10.1016/0009-3084(75)90067-5

10.1056/NEJM196609222751204

Westerman MP, 1970, J Lab Clin Med, 75, 893

10.1016/S0022-2275(20)39340-8

Cooper RA, 1977, Clin Res, 25, 454A

10.1002/path.1711180402

Grandison AS, 1976, Biochem Soc Trans, 4, 645, 10.1042/bst0040645

10.1016/0005-2760(75)90166-6

10.1016/0005-2736(76)90063-8

10.1056/NEJM197406062902303

10.1001/archinte.1956.00250190017001

10.1016/0005-2736(68)90056-4

10.1016/0005-2736(74)90300-9

10.1038/264646a0

10.1016/0005-2736(75)90125-X

10.1016/0005-2736(76)90287-X

10.1016/0005-2736(71)90147-7

10.1172/JCI107971

10.1021/bi00667a012

Shattil SJ, 1977, J Lab Clin Med, 89, 341

10.1056/NEJM197402212900805

10.1016/S0021-9258(17)40389-9

10.1016/0005-2736(73)90159-4

10.1016/0005-2736(73)90232-0

10.1073/pnas.70.2.480

10.1038/255684a0

10.1073/pnas.73.12.4526

10.1021/bi00624a027

10.1016/0005-2736(73)90158-2

10.1126/science.822515

Fogelman AM, 1977, J Biol Chem, 265, 644, 10.1016/S0021-9258(17)32767-9

10.1016/0005-2736(76)90200-5

10.3109/00365516809077001

10.1172/JCI105775

10.1172/JCI105676

10.1126/science.172.3982.475

10.1172/JCI107273

10.1016/0005-2736(73)90429-X

Thông tin
Thông tin xuất bản

Wiley

Tập 8 Số 4

413-430

Thông tin tác giả